Wisdomtree Biorevolution Etf Net Income
| WDNA Etf | USD 17.98 0.22 1.21% |
As of the 2nd of February, WisdomTree BioRevolution maintains the Mean Deviation of 1.15, market risk adjusted performance of 0.1343, and Downside Deviation of 1.36. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of WisdomTree BioRevolution, as well as the relationship between them.
WisdomTree BioRevolution's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing WisdomTree BioRevolution's valuation are provided below:WisdomTree BioRevolution does not presently have any fundamental gauges for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. WisdomTree | Build AI portfolio with WisdomTree Etf |
Understanding WisdomTree BioRevolution requires distinguishing between market price and book value, where the latter reflects WisdomTree's accounting equity. The concept of intrinsic value—what WisdomTree BioRevolution's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push WisdomTree BioRevolution's price substantially above or below its fundamental value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, WisdomTree BioRevolution's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
WisdomTree BioRevolution 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to WisdomTree BioRevolution's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of WisdomTree BioRevolution.
| 11/04/2025 |
| 02/02/2026 |
If you would invest 0.00 in WisdomTree BioRevolution on November 4, 2025 and sell it all today you would earn a total of 0.00 from holding WisdomTree BioRevolution or generate 0.0% return on investment in WisdomTree BioRevolution over 90 days. WisdomTree BioRevolution is related to or competes with Global X, Themes Cash, ETF Managers, VanEck ETF, Themes Cybersecurity, Global X, and FT Vest. The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally wil... More
WisdomTree BioRevolution Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure WisdomTree BioRevolution's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess WisdomTree BioRevolution upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.36 | |||
| Information Ratio | 0.0599 | |||
| Maximum Drawdown | 5.68 | |||
| Value At Risk | (2.08) | |||
| Potential Upside | 2.83 |
WisdomTree BioRevolution Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for WisdomTree BioRevolution's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as WisdomTree BioRevolution's standard deviation. In reality, there are many statistical measures that can use WisdomTree BioRevolution historical prices to predict the future WisdomTree BioRevolution's volatility.| Risk Adjusted Performance | 0.0706 | |||
| Jensen Alpha | 0.088 | |||
| Total Risk Alpha | 0.0518 | |||
| Sortino Ratio | 0.0645 | |||
| Treynor Ratio | 0.1243 |
WisdomTree BioRevolution February 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0706 | |||
| Market Risk Adjusted Performance | 0.1343 | |||
| Mean Deviation | 1.15 | |||
| Semi Deviation | 1.22 | |||
| Downside Deviation | 1.36 | |||
| Coefficient Of Variation | 1103.4 | |||
| Standard Deviation | 1.46 | |||
| Variance | 2.14 | |||
| Information Ratio | 0.0599 | |||
| Jensen Alpha | 0.088 | |||
| Total Risk Alpha | 0.0518 | |||
| Sortino Ratio | 0.0645 | |||
| Treynor Ratio | 0.1243 | |||
| Maximum Drawdown | 5.68 | |||
| Value At Risk | (2.08) | |||
| Potential Upside | 2.83 | |||
| Downside Variance | 1.84 | |||
| Semi Variance | 1.48 | |||
| Expected Short fall | (1.21) | |||
| Skewness | 0.2738 | |||
| Kurtosis | (0.40) |
WisdomTree BioRevolution Backtested Returns
WisdomTree BioRevolution appears to be very steady, given 3 months investment horizon. WisdomTree BioRevolution shows Sharpe Ratio of 0.18, which attests that the etf had a 0.18 % return per unit of risk over the last 3 months. We have found thirty technical indicators for WisdomTree BioRevolution, which you can use to evaluate the volatility of the etf. Please utilize WisdomTree BioRevolution's Mean Deviation of 1.15, downside deviation of 1.36, and Market Risk Adjusted Performance of 0.1343 to validate if our risk estimates are consistent with your expectations. The entity maintains a market beta of 0.98, which attests to possible diversification benefits within a given portfolio. WisdomTree BioRevolution returns are very sensitive to returns on the market. As the market goes up or down, WisdomTree BioRevolution is expected to follow.
Auto-correlation | 0.76 |
Good predictability
WisdomTree BioRevolution has good predictability. Overlapping area represents the amount of predictability between WisdomTree BioRevolution time series from 4th of November 2025 to 19th of December 2025 and 19th of December 2025 to 2nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of WisdomTree BioRevolution price movement. The serial correlation of 0.76 indicates that around 76.0% of current WisdomTree BioRevolution price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, WisdomTree BioRevolution reported net income of 0.0. This indicator is about the same for the WisdomTree average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
WisdomTree Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WisdomTree BioRevolution's current stock value. Our valuation model uses many indicators to compare WisdomTree BioRevolution value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WisdomTree BioRevolution competition to find correlations between indicators driving WisdomTree BioRevolution's intrinsic value. More Info.WisdomTree BioRevolution is rated first in beta as compared to similar ETFs. It is rated first in one year return as compared to similar ETFs reporting about 16.35 of One Year Return per Beta. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WisdomTree BioRevolution's earnings, one of the primary drivers of an investment's value.Fund Asset Allocation for WisdomTree BioRevolution
The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .Asset allocation divides WisdomTree BioRevolution's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors for a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will manage securities in the fund's portfolio as market conditions and the fund's objectives change.
WisdomTree Fundamentals
| Beta | 1.59 | |||
| Total Asset | 4.54 M | |||
| One Year Return | 26.00 % | |||
| Three Year Return | 1.60 % | |||
| Net Asset | 4.54 M | |||
| Equity Positions Weight | 100.00 % |
About WisdomTree BioRevolution Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WisdomTree BioRevolution's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WisdomTree BioRevolution using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WisdomTree BioRevolution based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether WisdomTree BioRevolution offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of WisdomTree BioRevolution's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Wisdomtree Biorevolution Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Wisdomtree Biorevolution Etf:Check out You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Understanding WisdomTree BioRevolution requires distinguishing between market price and book value, where the latter reflects WisdomTree's accounting equity. The concept of intrinsic value—what WisdomTree BioRevolution's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push WisdomTree BioRevolution's price substantially above or below its fundamental value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, WisdomTree BioRevolution's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.